Jyong Biotech Ltd. (MENS)
MENS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.04
-2.86% on the day
Market cap
$155.1M
Micro cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MENS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Taiwan |
| IPO year | 2025 |
| SEC CIK | 0001954488 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | E9 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B4 | 2025-06-18 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-05-15 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-02-06 |
Source: SEC EDGAR submissions feed, 73 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ORGO | Organogenesis Holdings Inc. | $1.21 | -1.63% | $155.7M |
| NKTX | Nkarta Inc. | $2.10 | -3.23% | $150.4M |
| DERM | Journey Medical Corporation | $5.68 | -3.89% | $160.3M |
| CNTN | Canton Strategic Holdings Inc. | $2.02 | -4.26% | $161.0M |
| MSLE | Satellos Bioscience Inc. | $7.04 | -1.81% | $149.4M |
| NBP | NovaBridge Biosciences | $1.29 | -2.27% | $148.8M |
| ADAG | Adagene Inc. | $2.46 | -10.22% | $162.5M |
| CUE | Cue Biopharma Inc. | $19.57 | -20.48% | $142.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier